Pfizer 2010 Annual Report Download - page 56

Download and view the complete annual report

Please find page 56 of the 2010 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 120

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120

Consolidated Balance Sheets
Pfizer Inc. and Subsidiary Companies
AS OF DECEMBER 31,
(MILLIONS, EXCEPT PREFERRED STOCK ISSUED AND PER COMMON SHARE DATA) 2010 2009
Assets
Cash and cash equivalents $ 1,735 $ 1,978
Short-term investments 26,277 23,991
Accounts receivable, less allowance for doubtful accounts: 2010—$217; 2009—$176 14,612 14,645
Short-term loans 467 1,195
Inventories 8,405 12,403
Taxes and other current assets 8,411 6,962
Assets held for sale 561 496
Total current assets 60,468 61,670
Long-term investments and loans 9,748 13,122
Property, plant and equipment, less accumulated depreciation 19,123 22,780
Goodwill 43,947 42,376
Identifiable intangible assets, less accumulated amortization 57,558 68,015
Taxes and other noncurrent assets 4,170 4,986
Total assets $195,014 $212,949
Liabilities and Shareholders’ Equity
Short-term borrowings, including current portion of long-term debt: 2010—$3,502; 2009—$27 $ 5,623 $ 5,469
Accounts payable 4,026 4,370
Dividends payable 1,601 1,454
Income taxes payable 946 10,107
Accrued compensation and related items 2,108 2,242
Other current liabilities 14,305 13,583
Total current liabilities 28,609 37,225
Long-term debt 38,410 43,193
Pension benefit obligations 6,201 6,392
Postretirement benefit obligations 3,035 3,243
Noncurrent deferred tax liabilities 18,648 17,839
Other taxes payable 6,245 9,000
Other noncurrent liabilities 5,601 5,611
Total liabilities 106,749 122,503
Preferred stock, without par value, at stated value; 27 shares authorized; issued: 2010—1,279;
2009—1,511 52 61
Common stock, $0.05 par value; 12,000 shares authorized; issued: 2010—8,876; 2009—8,869 444 443
Additional paid-in capital 70,760 70,497
Employee benefit trusts (7) (333)
Treasury stock, shares at cost; 2010—864; 2009—799 (22,712) (21,632)
Retained earnings 42,716 40,426
Accumulated other comprehensive (loss)/income (3,440) 552
Total Pfizer Inc. shareholders’ equity 87,813 90,014
Equity attributable to noncontrolling interests 452 432
Total shareholders’ equity 88,265 90,446
Total liabilities and shareholders’ equity $195,014 $212,949
See Notes to Consolidated Financial Statements, which are an integral part of these statements.
54 2010 Financial Report